Delivery Order SPE2DB22D2206-SPE2DB24FFZ37

Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563715246 REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract has a potential value of $1,629.69 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing pharmaceutical products and medical supplies to DLA Troop Support Medical facilities in...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,295.31 contract is for the provision of "REFRESH PLUS 0.5% EYE DROPS UD 70S" to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,974.92 contract is for the provision of "REFRESH PLUS 0.5% EYE DROPS 30S" pharmaceutical products. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen Drug Corp to deliver a...
This $1,093.42 firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4,561,837,935 units of REFRESH PLUS 0.5% EYE DROPS UD 50S, a prescription ophthalmic product, with a period of performance ending on August 18, 2023. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract, valued at $2,510.87, has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to the Department of Defense through various contract vehicles. This...
This is a $1,458.64 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of "REFRESH PLUS 0.5% EYE DROPS 30S" pharmaceutical products. This order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $6,377.97. The contract is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" and has a firm fixed price pricing type. The ultimate completion date is May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract has a ceiling value of $1,196.48 and a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not part of a set-aside program. Additionally, Amerisourcebergen Drug Corp holds an...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a potential value of $2,062.76 and a period of performance through March 7, 2024. Amerisourcebergen Drug Corp is providing 4563881174 REFRESH PLUS 0.5% EYE DROPS UD 70S, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,633.20 firm fixed-price delivery order is for the supply of 4566709070 REFRESH PLUS 0.5% EYE DROPS UD 70S. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FFZ37
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4563894359 REFRESH PLUS 0.5% EYE DROPS 30S. The contract has a completion date of March 8, 2024 and a potential value of $1,053.44. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.

Generated 6/6/24, 10:20 AM